PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Gene therapy for metastatic melanoma in mice produces complete remission

Gene therapy for metastatic melanoma in mice produces complete remission
2010-11-19
(Press-News.org) INDIANAPOLIS – A potent anti-tumor gene introduced into mice with metastatic melanoma has resulted in permanent immune reconfiguration and produced a complete remission of their cancer, according to an article to be published in the December 2010 issue of the Journal of Clinical Investigation. The online version is now available.

Indiana University School of Medicine researchers used a modified lentivirus to introduce a potent anti-melanoma T cell receptor gene into the hematopoietic stem cells of mice. Hematopoietic stem cells are the bone marrow cells that produce all blood and immune system cells.

The T cell gene, which recognizes a specific protein found on the surface of melanoma, was isolated and cloned from a patient with melanoma. The gene-modified stems cells were then transplanted back into hosts and found to eradicate metastatic melanoma for the lifetime of the mice.

"We found that the transplantation of gene-modified hematopoietic stem cells results in a new host immune system and the complete elimination of tumor," reported Christopher E. Touloukian, M.D., an assistant professor of surgery and immunology at the IU School of Medicine and a member of the Indiana University Melvin and Bren Simon Cancer Center. "To date, cancer immunotherapies have been hampered by limited and diminishing immune responses over time. We believe this type of translational model opens new doors for patients with melanoma and potentially other cancers by taking advantage of the potent regenerative capacity of hematopoietic stem cells and new advances in gene therapy."

This research was funded by a National Institutes of Health grant.

It has paved the way for a new clinical trial in humans funded by the V Foundation for Cancer Research. The pilot phase I trial will involve treatment of 12 patients and focus primarily on the safety and efficacy of the therapy, said Dr. Touloukian, who is the senior author on the JCI paper and the principal investigator for the clinical study. The clinical trial is expected to begin accruing patients by late 2011.

In 2010, more than 68,000 patients will be diagnosed with melanoma and the disease will be associated with approximately 9,000 deaths. The state of Indiana has the 11th highest rate of melanoma incidence of all 50 states. Current treatments for metastatic melanoma, though exciting and innovative, have been highly toxic and largely unsuccessful with the most patients dying within 6 to 12 months after diagnosis.



INFORMATION:


[Attachments] See images for this press release:
Gene therapy for metastatic melanoma in mice produces complete remission

ELSE PRESS RELEASES FROM THIS DATE:

Well-known molecule may be behind alcohol's benefits to heart health

2010-11-19
Many studies support the assertion that moderate drinking is beneficial when it comes to cardiovascular health, and for the first time scientists have discovered that a well-known molecule, called Notch, may be behind alcohol's protective effects. Down the road, this finding could help scientists create a new treatment for heart disease that mimics the beneficial influence of modest alcohol consumption. "Any understanding of a socially acceptable, modifiable activity that many people engage in, like drinking, is useful as we continue to search for new ways to improve ...

Pushing black-hole mergers to the extreme: RIT scientists achieve 100:1 mass ratio

Pushing black-hole mergers to the extreme: RIT scientists achieve 100:1 mass ratio
2010-11-19
Scientists have simulated, for the first time, the merger of two black holes of vastly different sizes, with one mass 100 times larger than the other. This extreme mass ratio of 100:1 breaks a barrier in the fields of numerical relativity and gravitational wave astronomy. Until now, the problem of simulating the merger of binary black holes with extreme size differences had remained an unexplored region of black-hole physics. "Nature doesn't collide black holes of equal masses," says Carlos Lousto, associate professor of mathematical sciences at Rochester Institute ...

Cameroon timber tax study shows challenges of distributing REDD payments to local communities

2010-11-19
YAOUNDÉ, Cameroon (19 November 2010) – A new study finds a lack of transparency and corruption are reducing the impact of an initiative in Cameroon that channels a portion of national timber levies to rural forest communities. The study highlights the challenges of using a climate change pact to do something similar in forested regions around the world. In an article published in the peer-reviewed journal International Forestry Review, scientists at the Center for International Forestry Research (CIFOR) examined how revenues from a tax paid by logging companies in Cameroon, ...

Researchers insert identification codes into mouse embryos

2010-11-19
Researchers from the Department of Cell Biology, Physiology and Immunology at Universitat Autònoma de Barcelona (UAB), in collaboration with researchers from the Institute of Microelectronics of Barcelona (IMB-CNM) of the Spanish National Research Council (CSIC), have developed an identification system for oocytes and embryos in which each can be individually tagged using silicon barcodes. Researchers are now working to perfect the system and soon will test it with human oocytes and embryos. The research, published online in Human Reproduction, represents a first step ...

Laboratory studies show promise for new multiple sclerosis treatment

2010-11-19
Successfully treating and reversing the effects of multiple sclerosis, or MS, may one day be possible using a drug originally developed to treat chronic pain, according to Distinguished Professor Linda Watkins of the University of Colorado at Boulder. Watkins and her colleagues in CU-Boulder's department of psychology and neuroscience discovered that a single injection of a compound called ATL313 -- an anti-inflammatory drug being developed to treat chronic pain -- stopped the progression of MS-caused paralysis in rats for weeks at a time. Lisa Loram, a senior research ...

Bacteria use 'toxic darts' to disable each other, according to UCSB scientists

Bacteria use toxic darts to disable each other, according to UCSB scientists
2010-11-19
(Santa Barbara, Calif.) –– In nature, it's a dog-eat-dog world, even in the realm of bacteria. Competing bacteria use "toxic darts" to disable each other, according to a new study by UC Santa Barbara biologists. Their research is published in the journal Nature. "The discovery of toxic darts could eventually lead to new ways to control disease-causing pathogens," said Stephanie K. Aoki, first author and postdoctoral fellow in UCSB's Department of Molecular, Cellular, and Developmental Biology (MCDB). "This is important because resistance to antibiotics is on the rise." Second ...

Wellness programs provide high returns, research reveals

2010-11-19
Employee wellness programs have often been viewed as a nice extra, not a strategic imperative. But the data demonstrate otherwise, according to a team of researchers led by Leonard L. Berry of Texas A&M University, Ann M. Mirabito of Baylor University and William B. Baun of the University of Texas MD Anderson Cancer Center. Their research shows that the return on investment on comprehensive, well-run employee wellness programs is impressive — sometimes as high as six to one. The findings are compiled in a comprehensive piece in the December issue of Harvard Business ...

Spacecraft flew through 'snowstorm' on encounter with comet Hartley 2

Spacecraft flew through snowstorm on encounter with comet Hartley 2
2010-11-19
COLLEGE PARK, Md. -- On its recent trip by comet Hartley 2, the Deep Impact spacecraft took the first pictures of, and flew through, a storm of fluffy particles of water ice being spewed out by carbon dioxide jets coming from the rough ends of the comet. The resulting images and data shed new light on the nature and composition of comets, according to the University of Maryland-led EPOXI science team, which today announced its latest findings and released the first images of this comet created snowstorm. See images at: http://epoxi.umd.edu/index.shtml "When we visited ...

Latest American Chemical Society podcast: New water filter kills disease-causing bacteria

2010-11-19
WASHINGTON, Nov. 18, 2010 — The latest episode in the American Chemical Society's (ACS) award-winning podcast series, "Global Challenges/Chemistry Solutions," focuses on development and successful initial tests of an inexpensive new filtering technology that kills up to 98 percent of disease-causing bacteria in water in just seconds without clogging. The technology could aid many of the almost one billion people lacking access to clean, safe drinking water. A report on the work appears in the American Chemical Society's monthly journal Nano Letters. Most water purifiers ...

Researchers identify PTSD measures for use in traumatic brain injury research

2010-11-19
(Boston) - Five U.S. federal agencies recently cosponsored a set of expert work groups to formulate common data elements for research related to psychological adjustment and traumatic brain injury (TBI). Danny G. Kaloupek, PhD, associate professor of psychiatry and behavioral neuroscience at Boston University School of Medicine, chaired the work group on posttraumatic stress disorder (PTSD). Dr. Kaloupek's work at the National Center for PTSD at VA Boston Healthcare helped to guide identification of key PTSD-related characteristics and evidence-based measures that might ...

LAST 30 PRESS RELEASES:

Scientists create new overwintering sites for monarch butterflies on a warming planet

Laser solid-phase synthesis of graphene shell-encapsulated high-entropy alloy nanoparticles

New catalyst breakthrough: Improving oxygen reduction reaction with dual nitrogen sources

Protein shakeup: Researchers uncover new function of a protein that may unlock age-related illnesses

UMD-led study could ‘pave the way’ for improved treatment of premature aging disease

How chain IVF clinics improve infertility treatment

Study shows that Rett syndrome in females is not just less severe, but different

Big data, real world, multi-state study finds RSV vaccine highly effective in protecting older adults against severe disease, hospitalization and death

Manliness concerns impede forgiveness of coworkers

Better ocean connectivity boosts reef fish populations

Two 2024 Nobel laureates are affiliates of the Marine Biological Laboratory, Woods Hole

Ultra-processed foods pose unique dangers for people with type 2 diabetes

When hurricanes hit, online chatter drowns out safety messaging

Study seeks rapid, paper-based test to detect cancer cells in cerebrospinal fluid

Raising happy eaters: Unlocking the secrets of childhood appetite

The Society of Thoracic Surgeons launches two new thoracic surgery risk calculators

FAPESP and CNR plan to launch joint call for proposals in April 2025

Smaller, more specific academic journals have more sway over policy

Medicaid ACOs have not yet improved care for kids with asthma

New study sheds light on lily toxicity in cats; outpatient treatment may be viable option

A new benchmark to recognize the hardest problems in materials science

Why do we love carbs? The origins predate agriculture and maybe even our split from Neanderthals

Key protein for the biosynthesis of defense steroids in solanaceous plants discovered

Global CO2 emissions from forest fires increase by 60%

AI-assisted deliberation can help people with different views find common ground

Special Issue explores factors influencing democratic attitudes, and what’s at stake for science in the U.S. after November election

Extratropical forest fire emissions are increasing as climate changes

A new approach to capturing complex mixtures of organic chemicals in blood, evaluated in pregnant women

Gut instincts: Intestinal nutrient sensors

Catching prey with grappling hooks and cannons

[Press-News.org] Gene therapy for metastatic melanoma in mice produces complete remission